Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Teladoc Health, Inc. (TDOC) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Teladoc Health, Inc.. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1477449.
Total stock buying since 2015: $575,550.
Total stock sales since 2015: $552,066,474.
Total stock option exercises since 2015: $34,522,816.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2025 | 0 | $0 | 144,784 | $1,151,359 | 448,374 | $0 |
2024 | 19,000 | $140,814 | 193,087 | $2,113,548 | 311,625 | $20,475 |
2023 | 0 | $0 | 290,488 | $6,910,745 | 503,841 | $20,474 |
2022 | 0 | $0 | 56,082 | $3,064,778 | 170,741 | $44,600 |
2021 | 0 | $0 | 1,309,726 | $276,101,363 | 1,145,194 | $6,104,439 |
2020 | 0 | $0 | 759,831 | $142,947,318 | 819,526 | $10,449,134 |
2019 | 0 | $0 | 435,917 | $28,258,142 | 511,715 | $6,486,818 |
2018 | 0 | $0 | 1,056,142 | $57,783,087 | 941,064 | $9,663,791 |
2017 | 0 | $0 | 893,797 | $21,735,751 | 276,550 | $1,114,617 |
2016 | 29,900 | $318,509 | 722,865 | $12,000,383 | 177,886 | $617,751 |
2015 | 5,433 | $116,227 | 0 | $0 | 897 | $717 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2019-05-01 | Mcclennen Peter A (President) | Sale | 19,594 | 60.03 | 1,176,227 |
2019-05-01 | Mcclennen Peter A (President) | Option Ex | 19,594 | 35.52 | 696,076 |
2019-04-16 | Gorevic Jason N (Chief Executive Officer) | Sale | 30,000 | 53.04 | 1,591,200 |
2019-04-16 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 30,000 | 1.67 | 50,100 |
2019-04-11 | Levy Lewis (Chief Medical Officer) | Sale | 675 | 56.80 | 38,340 |
2019-04-11 | Levy Lewis (Chief Medical Officer) | Option Ex | 675 | 37.00 | 24,975 |
2019-04-05 | Mcclennen Peter A (President) | Sale | 13,063 | 57.14 | 746,419 |
2019-04-05 | Mcclennen Peter A (President) | Option Ex | 13,063 | 32.50 | 424,547 |
2019-04-04 | Turitz Andrew (SVP - Business Development) | Sale | 31,960 | 55.82 | 1,784,007 |
2019-04-04 | Turitz Andrew (SVP - Business Development) | Option Ex | 31,960 | 24.35 | 778,321 |
2019-03-27 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 20,073 | 6.94 | 139,306 |
2019-03-19 | Gorevic Jason N (Chief Executive Officer) | Sale | 30,000 | 63.16 | 1,894,800 |
2019-03-19 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 30,000 | 1.67 | 50,100 |
2019-03-13 | Bucaria Michelle (Chief Human Resources Officer) | Sale | 1,188 | 60.00 | 71,280 |
2019-03-11 | Bucaria Michelle (Chief Human Resources Officer) | Option Ex | 2,649 | 37.75 | 99,999 |
2019-03-08 | Bucaria Michelle (Chief Human Resources Officer) | Option Ex | 1,987 | .00 | 0 |
2019-03-06 | Verstraete Stephany (Chief Marketing Officer) | Option Ex | 1,925 | .00 | 0 |
2019-03-06 | Turitz Andrew (SVP - Business Development) | Option Ex | 1,856 | .00 | 0 |
2019-03-06 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 1,953 | .00 | 0 |
2019-03-06 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 12,500 | .00 | 0 |
2019-03-05 | Goldstein Michael | Sale | 20,500 | 63.40 | 1,299,700 |
2019-03-05 | Goldstein Michael | Option Ex | 20,500 | 8.71 | 178,555 |
2019-03-04 | Levy Lewis (Chief Medical Officer) | Option Ex | 2,881 | .00 | 0 |
2019-03-04 | Verstraete Stephany (Chief Marketing Officer) | Option Ex | 3,169 | .00 | 0 |
2019-03-04 | Turitz Andrew (SVP - Business Development) | Option Ex | 2,305 | .00 | 0 |
2019-03-04 | Cappucci Gabriel R. (Senior VP, Controller and CAO) | Option Ex | 1,767 | .00 | 0 |
2019-03-04 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 3,745 | .00 | 0 |
2019-03-04 | Mcclennen Peter A (President) | Option Ex | 8,283 | .00 | 0 |
2019-03-04 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 13,281 | .00 | 0 |
2019-02-19 | Gorevic Jason N (Chief Executive Officer) | Sale | 30,000 | 69.68 | 2,090,400 |
2019-02-19 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 30,000 | 1.37 | 41,100 |
2019-02-15 | Levy Lewis (Chief Medical Officer) | Sale | 1,285 | 67.21 | 86,364 |
2019-02-15 | Levy Lewis (Chief Medical Officer) | Option Ex | 1,285 | 35.45 | 45,553 |
2019-02-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 5,550 | 61.69 | 342,379 |
2019-02-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 5,550 | 13.21 | 73,287 |
2019-01-18 | Gorevic Jason N (Chief Executive Officer) | Sale | 30,000 | 63.04 | 1,891,200 |
2019-01-18 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 30,000 | 1.07 | 32,100 |
2019-01-15 | Levy Lewis (Chief Medical Officer) | Sale | 1,284 | 57.00 | 73,188 |
2019-01-15 | Levy Lewis (Chief Medical Officer) | Option Ex | 1,284 | 35.45 | 45,517 |
2019-01-08 | Levy Lewis (Chief Medical Officer) | Sale | 645 | 55.00 | 35,475 |
2019-01-08 | Levy Lewis (Chief Medical Officer) | Option Ex | 645 | 35.45 | 22,865 |
2019-01-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 5,500 | 53.80 | 295,900 |
2019-01-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 5,550 | 13.21 | 73,287 |
2018-12-20 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 97,535 | 2.60 | 254,078 |
2018-12-19 | Gorevic Jason N (Chief Executive Officer) | Sale | 30,000 | 49.55 | 1,486,500 |
2018-12-19 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 30,000 | 1.07 | 32,100 |
2018-12-18 | Turitz Andrew (SVP - Business Development) | Sale | 2,734 | 50.01 | 136,727 |
2018-12-18 | Turitz Andrew (SVP - Business Development) | Option Ex | 2,734 | 6.01 | 16,431 |
2018-12-17 | Levy Lewis (Chief Medical Officer) | Sale | 640 | 50.00 | 32,000 |
2018-12-17 | Levy Lewis (Chief Medical Officer) | Option Ex | 640 | 35.45 | 22,688 |
2018-12-13 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 7,343 | 9.64 | 70,786 |
2018-12-10 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 5,550 | 54.19 | 300,754 |
2018-12-10 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 5,550 | 13.21 | 73,287 |
2018-12-04 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 10,000 | 64.96 | 649,599 |
2018-12-03 | Turitz Andrew (SVP - Business Development) | Sale | 8,202 | 64.14 | 526,076 |
2018-12-03 | Turitz Andrew (SVP - Business Development) | Option Ex | 8,202 | 6.01 | 49,294 |
2018-11-20 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 2,291 | 15.76 | 36,113 |
2018-11-19 | Gorevic Jason N (Chief Executive Officer) | Sale | 35,000 | 54.80 | 1,918,000 |
2018-11-19 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 30,000 | 1.07 | 32,100 |
2018-11-15 | Levy Lewis (Chief Medical Officer) | Sale | 1,284 | 57.24 | 73,496 |
2018-11-15 | Levy Lewis (Chief Medical Officer) | Option Ex | 1,284 | 35.45 | 45,517 |
2018-11-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 5,549 | 67.18 | 372,781 |
2018-11-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 5,549 | 13.21 | 73,274 |
2018-11-07 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 8,082 | 12.06 | 97,468 |
2018-11-05 | Mcclennen Peter A (President) | Sale | 69,224 | 66.77 | 4,622,086 |
2018-11-05 | Mcclennen Peter A (President) | Option Ex | 69,224 | 16.25 | 1,124,890 |
2018-11-02 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 10,000 | 70.13 | 701,300 |
2018-10-31 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 2,284 | 6.01 | 13,726 |
2018-10-17 | Gorevic Jason N (Chief Executive Officer) | Sale | 25,000 | 70.29 | 1,757,250 |
2018-10-17 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 10,000 | 11.20 | 111,969 |
2018-10-15 | Levy Lewis (Chief Medical Officer) | Sale | 1,285 | 67.00 | 86,095 |
2018-10-15 | Levy Lewis (Chief Medical Officer) | Option Ex | 1,285 | 35.45 | 45,553 |
2018-10-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 5,551 | 73.83 | 409,830 |
2018-10-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 5,551 | 13.21 | 73,300 |
2018-09-25 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 35,000 | 80.37 | 2,812,950 |
2018-09-20 | Verstraete Stephany (Chief Marketing Officer) | Sale | 18,000 | 74.92 | 1,348,560 |
2018-09-20 | Verstraete Stephany (Chief Marketing Officer) | Option Ex | 18,000 | 17.99 | 323,820 |
2018-09-19 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 32,209 | 11.20 | 360,644 |
2018-09-17 | Levy Lewis (Chief Medical Officer) | Sale | 1,284 | 77.00 | 98,868 |
2018-09-17 | Levy Lewis (Chief Medical Officer) | Option Ex | 1,284 | 35.45 | 45,517 |
2018-09-17 | Gorevic Jason N (Chief Executive Officer) | Sale | 25,000 | 75.05 | 1,876,250 |
2018-09-10 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 5,550 | 77.67 | 431,068 |
2018-09-10 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 5,550 | 13.21 | 73,287 |
2018-09-04 | Turitz Andrew (SVP - Business Development) | Sale | 8,202 | 77.42 | 634,998 |
2018-09-04 | Turitz Andrew (SVP - Business Development) | Option Ex | 8,202 | 6.01 | 49,294 |
2018-08-16 | Gorevic Jason N (Chief Executive Officer) | Sale | 25,000 | 71.66 | 1,791,500 |
2018-08-15 | Levy Lewis (Chief Medical Officer) | Sale | 1,285 | 70.80 | 90,978 |
2018-08-15 | Levy Lewis (Chief Medical Officer) | Option Ex | 1,285 | 35.45 | 45,553 |
2018-08-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 5,549 | 67.25 | 373,170 |
2018-08-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 5,549 | 13.21 | 73,274 |
2018-07-16 | Levy Lewis (Chief Medical Officer) | Sale | 22,768 | 65.80 | 1,498,020 |
2018-07-16 | Levy Lewis (Chief Medical Officer) | Option Ex | 22,768 | 17.73 | 403,562 |
2018-07-16 | Mcclennen Peter A (President) | Sale | 91,072 | 65.84 | 5,996,635 |
2018-07-16 | Mcclennen Peter A (President) | Option Ex | 91,072 | 17.73 | 1,614,251 |
2018-07-16 | Gorevic Jason N (Chief Executive Officer) | Sale | 25,000 | 66.11 | 1,652,750 |
2018-07-10 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 20,000 | 63.00 | 1,260,000 |
2018-07-09 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 24,250 | 64.28 | 1,558,790 |
2018-07-09 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 23,114 | 13.21 | 305,220 |
2018-07-09 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 4,561 | 11.98 | 54,663 |
2018-07-03 | Turitz Andrew (SVP - Business Development) | Sale | 13,821 | 59.43 | 821,382 |
2018-07-03 | Turitz Andrew (SVP - Business Development) | Option Ex | 13,821 | 13.51 | 186,680 |
2018-06-28 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 16,659 | 9.64 | 160,592 |
2018-06-19 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 1,136 | .00 | 0 |
2018-06-15 | Gorevic Jason N (Chief Executive Officer) | Sale | 25,000 | 60.21 | 1,505,250 |
2018-05-25 | Darling Helen | Option Ex | 918 | .00 | 0 |
2018-05-25 | Multani Arneek | Option Ex | 918 | .00 | 0 |
2018-05-25 | Mawhinney Tom | Option Ex | 918 | .00 | 0 |
2018-05-25 | Frist William H. | Option Ex | 918 | .00 | 0 |
2018-05-25 | Shedlarz David L | Option Ex | 918 | .00 | 0 |
2018-05-25 | Goldstein Michael | Option Ex | 918 | .00 | 0 |
2018-05-25 | Mckinley Thomas | Option Ex | 918 | .00 | 0 |
2018-05-15 | Gorevic Jason N (Chief Executive Officer) | Sale | 25,000 | 48.93 | 1,223,250 |
2018-05-02 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 60,000 | 45.17 | 2,710,199 |
2018-05-02 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 44,560 | 17.14 | 570,751 |
2018-05-01 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 40,000 | 42.67 | 1,706,800 |
2018-04-30 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 8,548 | 11.44 | 97,789 |
2018-04-16 | Gorevic Jason N (Chief Executive Officer) | Sale | 25,000 | 41.36 | 1,034,000 |
2018-04-16 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 30,740 | 9.11 | 280,041 |
2018-04-06 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 13,970 | 6.47 | 90,455 |
2018-04-05 | Mawhinney Tom | Option Ex | 21,949 | 16.91 | 371,267 |
2018-04-04 | Mawhinney Tom | Option Ex | 12,249 | 10.84 | 132,779 |
2018-03-12 | Verstraete Stephany (Chief Marketing Officer) | Option Ex | 1,925 | .00 | 0 |
2018-03-12 | Gorevic Jason N (Chief Executive Officer) | Sale | 40,000 | 43.27 | 1,730,800 |
2018-03-07 | Mcclennen Peter A (President) | Sale | 27,533 | 43.01 | 1,184,194 |
2018-03-06 | Turitz Andrew (SVP - Business Development) | Sale | 9,312 | 41.96 | 391,844 |
2018-03-06 | Turitz Andrew (SVP - Business Development) | Option Ex | 10,192 | 11.15 | 185,870 |
2018-03-06 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 12,500 | .00 | 0 |
2018-03-05 | Turitz Andrew (SVP - Business Development) | Sale | 8,334 | 41.26 | 343,860 |
2018-03-05 | Turitz Andrew (SVP - Business Development) | Option Ex | 8,334 | 22.30 | 185,848 |
2018-03-05 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 19,314 | 41.05 | 792,839 |
2018-03-05 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 19,314 | 11.15 | 215,351 |
2018-03-02 | Turitz Andrew (SVP - Business Development) | Sale | 19,245 | 39.25 | 755,366 |
2018-03-02 | Turitz Andrew (SVP - Business Development) | Option Ex | 19,245 | 9.11 | 175,321 |
2018-03-02 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 27,809 | 38.62 | 1,073,983 |
2018-03-02 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 27,809 | 10.17 | 282,900 |
2018-03-02 | Goldstein Michael | Sale | 66,574 | 39.72 | 2,644,319 |
2018-03-02 | Goldstein Michael | Option Ex | 66,574 | 9.78 | 650,760 |
2018-02-28 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 100,000 | 39.60 | 3,960,000 |
2018-02-28 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 5,795 | .83 | 4,838 |
2018-02-22 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 32,971 | 4.56 | 150,446 |
2018-02-09 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 25,834 | 6.01 | 155,262 |
2018-01-22 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 20,746 | 6.01 | 124,683 |
2018-01-12 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 13,204 | 3.12 | 41,156 |
2017-12-04 | Gorevic Jason N (Chief Executive Officer) | Sale | 100,000 | 32.99 | 3,299,000 |
2017-12-04 | Snow David B Jr | Option Ex | 93,437 | 4.48 | 418,597 |
2017-12-04 | Hirschhorn Mark (Executive VP, COO & CFO) | Sale | 30,000 | 32.99 | 989,700 |
2017-11-27 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 34,316 | 1.37 | 47,012 |
2017-11-15 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 10,000 | 27.96 | 279,600 |
2017-11-02 | Gorevic Jason N (Chief Executive Officer) | Sale | 20,000 | 32.10 | 642,000 |
2017-11-02 | Gorevic Jason N (Chief Executive Officer) | Option Ex | 20,000 | 1.07 | 21,400 |
2017-10-17 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 10,000 | 34.03 | 340,300 |
2017-10-16 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 25,000 | 32.37 | 809,249 |
2017-10-02 | Gorevic Jason N (President & CEO) | Sale | 20,000 | 33.47 | 669,400 |
2017-10-02 | Gorevic Jason N (President & CEO) | Option Ex | 20,000 | 1.07 | 21,400 |
2017-10-02 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 10,000 | 34.04 | 340,400 |
2017-09-22 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 9,100 | 32.74 | 297,934 |
2017-09-21 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 15,900 | 31.46 | 500,214 |
2017-08-07 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 53,806 | 30.92 | 1,663,681 |
2017-08-07 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 53,806 | 10.17 | 547,368 |
2017-06-06 | Gorevic Jason N (President & CEO) | Sale | 6,602 | 32.88 | 217,073 |
2017-06-06 | Gorevic Jason N (President & CEO) | Option Ex | 6,602 | 1.07 | 7,064 |
2017-06-05 | Gorevic Jason N (President & CEO) | Sale | 13,389 | 32.89 | 440,364 |
2017-06-05 | Gorevic Jason N (President & CEO) | Option Ex | 13,389 | 1.07 | 14,326 |
2017-05-25 | Gorevic Jason N (President & CEO) | Sale | 5,600 | 29.57 | 165,592 |
2017-05-25 | Gorevic Jason N (President & CEO) | Option Ex | 5,600 | 1.07 | 5,992 |
2017-05-23 | Gorevic Jason N (President & CEO) | Sale | 9,700 | 29.56 | 286,732 |
2017-05-23 | Gorevic Jason N (President & CEO) | Option Ex | 9,700 | 1.07 | 10,379 |
2017-05-22 | Gorevic Jason N (President & CEO) | Sale | 4,700 | 29.58 | 139,026 |
2017-05-22 | Gorevic Jason N (President & CEO) | Option Ex | 4,700 | 1.07 | 5,029 |
2017-05-17 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 100,000 | 27.70 | 2,770,000 |
2017-05-08 | Gorevic Jason N (President & CEO) | Sale | 15,000 | 23.11 | 346,650 |
2017-05-08 | Gorevic Jason N (President & CEO) | Option Ex | 15,000 | 1.07 | 16,050 |
2017-04-19 | King Michael H. (Chief Sales Officer) | Sale | 5,000 | 25.75 | 128,750 |
2017-04-19 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 59,100 | 25.46 | 1,504,686 |
2017-01-26 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 900 | 20.00 | 18,000 |
2017-01-24 | Trident Capital Fund Vi Principals Fund Llc (10% Owner) | Sale | 250,000 | 15.79 | 3,947,500 |
2017-01-24 | Gorevic Jason N (President & CEO) | Sale | 100,000 | 15.79 | 1,579,000 |
2017-01-19 | King Michael H. (Chief Sales Officer) | Sale | 5,000 | 19.00 | 95,000 |
2017-01-17 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 10,000 | 17.84 | 178,400 |
2017-01-09 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 5,000 | 17.50 | 87,500 |
2016-12-15 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 5,000 | 16.60 | 83,000 |
2016-12-14 | Chp Iii Management, L.l.c. (10% Owner) | Sale | 324,000 | 16.23 | 5,258,520 |
2016-12-13 | Chp Iii Management, L.l.c. (10% Owner) | Sale | 176,000 | 16.59 | 2,919,840 |
2016-12-06 | King Michael H. (Chief Sales Officer) | Sale | 5,000 | 19.00 | 95,000 |
2016-11-16 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 5,000 | 17.55 | 87,750 |
2016-11-16 | Hirschhorn Mark (Executive VP, COO and CFO) | Option Ex | 7,500 | 1.07 | 8,025 |
2016-11-15 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 5,000 | 16.82 | 84,100 |
2016-11-10 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 4,300 | 17.50 | 75,250 |
2016-11-08 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 700 | 17.50 | 12,250 |
2016-10-17 | Hirschhorn Mark (Executive VP, COO and CFO) | Sale | 5,000 | 15.52 | 77,600 |
2016-08-31 | King Michael H. (Chief Sales Officer) | Sale | 15,000 | 17.56 | 263,400 |
2016-08-16 | Gorevic Jason N (President & CEO) | Sale | 40,000 | 17.92 | 716,800 |
2016-08-16 | Gorevic Jason N (President & CEO) | Option Ex | 40,000 | 1.07 | 42,800 |
2016-08-15 | Hirschhorn Mark (Executive VP and CFO) | Sale | 30,000 | 17.83 | 534,900 |
2016-08-15 | Hirschhorn Mark (Executive VP and CFO) | Option Ex | 20,000 | 1.07 | 21,400 |
2016-08-11 | King Michael H. (Chief Sales Officer) | Sale | 25,000 | 17.20 | 430,000 |
2016-08-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Sale | 52,865 | 16.64 | 879,673 |
2016-08-08 | Vandervoort Adam C (Chief Legal Officer, Secretary) | Option Ex | 52,865 | 9.15 | 483,979 |
2016-08-02 | Outland James K | Sale | 10,000 | 18.00 | 180,000 |
2016-07-15 | Gorevic Jason N (President & CEO) | Sale | 5,000 | 15.45 | 77,250 |
2016-07-15 | Gorevic Jason N (President & CEO) | Option Ex | 5,000 | 1.07 | 5,350 |
2016-06-29 | Outland James K | Sale | 10,000 | 15.00 | 150,000 |
2016-06-29 | Gorevic Jason N (President & CEO) | Sale | 5,000 | 15.01 | 75,050 |
2016-06-29 | Gorevic Jason N (President & CEO) | Option Ex | 5,000 | 1.07 | 5,350 |
2016-03-17 | Outland James K | Buy | 10,000 | 10.70 | 107,000 |
2016-03-17 | Felsenthal Martin R | Buy | 9,900 | 10.61 | 105,009 |
2016-03-17 | Mead Dana G Jr. | Buy | 10,000 | 10.65 | 106,500 |
2016-03-07 | Hirschhorn Mark (Executive VP and CFO) | Option Ex | 32,521 | 1.07 | 34,797 |
2016-01-21 | Hirschhorn Mark (Executive VP and CFO) | Option Ex | 15,000 | 1.07 | 16,050 |
2015-11-10 | King Michael H. (Chief Sales Officer) | Buy | 933 | 15.86 | 14,797 |
2015-09-10 | Frist William H. (Director) | Buy | 4,500 | 22.54 | 101,430 |
2015-07-13 | Outland James K | Option Ex | 897 | .80 | 717 |
Insider trading activities including stock purchases, stock sales, and option exercises of TDOC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Teladoc Health, Inc. (symbol TDOC, CIK number 1477449) see the Securities and Exchange Commission (SEC) website.